Viewing Study NCT00137969


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-25 @ 8:20 PM
Study NCT ID: NCT00137969
Status: COMPLETED
Last Update Posted: 2019-08-20
First Post: 2005-08-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Sponsor: Genentech, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: U2971g
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators